Applied Materials vs. ASML: Which Tech Stock Is a Better Buy in 2026?

ASML is presented as the preferred 2026 semiconductor-equipment investment, supported by its virtual EUV lithography monopoly, 2025 revenue growth of 15.6% to $38.1 billion, 29.4% net margin, and $12.4 billion in free cash flow. Applied Materials generated $28.4 billion in fiscal 2025 revenue, up 4.4%, with a 24.7% margin and $5.7 billion of free cash flow, while trading at a modestly lower forward P/E of 37.4x versus ASML's 39.3x. The analysis argues ASML's monopoly pricing power justifies its premium valuation, although both companies face export-control, China exposure, customer concentration, supply-chain, and semiconductor-cycle risks.

Analysis

The relevant distinction is not monopoly versus diversification, but incremental wafer-fab-equipment (WFE) sensitivity. ASML captures the most constrained portion of leading-edge node transitions, so a sustained increase in TSM/NVDA-related advanced-node demand should support both pricing and backlog visibility; however, it is also exposed to a narrow set of very large shipment milestones and acceptance timing. AMAT has broader exposure to mature-node, DRAM/NAND, advanced packaging and process-intensity spending, making it the higher-beta recovery vehicle if memory WFE improves, but also more vulnerable if China-related mature-node demand is curtailed.

The apparent valuation gap is insufficient by itself to justify AMAT over ASML: a modest forward-P/E discount does not compensate for potentially lower terminal margins if export rules constrain a meaningful customer cohort or if Chinese domestic toolmakers gain share in non-leading-edge deposition/etch steps. Conversely, consensus may be underestimating that ASML's High-NA ramp can dilute near-term gross margin and consume customer capex before volume economics arrive. Watch TSM, Samsung and Intel capex commentary over the next 1-3 months; ASML reacts most to leading-edge logic timing, while AMAT needs evidence that memory utilization and packaging investment are broadening.

Near term, the article is unlikely to be a standalone catalyst because monopoly and export-control exposure are well understood. Over 6-18 months, the more differentiated outcome is a bifurcation between AI-driven leading-edge spending and a potentially oversupplied mature-node market: that favors ASML/TSM over AMAT and China-exposed WFE peers. The thesis fails if leading-edge customers defer EUV/High-NA purchase commitments, or if memory and packaging capex reaccelerate enough to lift AMAT's earnings revisions faster than ASML's.

Key Decisions for Investors

• Initiate a 6-12 month pair: long ASML / short AMAT in equal dollar amounts. Target relative outperformance of 10-15% if leading-edge logic capex remains resilient while export restrictions or mature-node oversupply pressure AMAT; exit if AMAT's next two quarters show broad-based order acceleration and ASML reports material EUV shipment deferrals.
• Maintain/establish long TSM as the cleaner downstream confirmation of the ASML thesis, sized smaller than ASML because of Taiwan geopolitical beta. Add only after capex guidance confirms advanced-node demand is converting into equipment orders; a meaningful capex cut or weaker N2 utilization would invalidate the setup.
• Use AMAT as a watch-list long rather than an immediate outright purchase: require independent evidence of memory-WFE recovery, rising advanced-packaging orders, and stable China revenue exposure. If those indicators emerge, AMAT could outperform ASML over a 3-6 month cyclical rebound despite its weaker structural moat.
• Do not use INTC as a direct ASML proxy until foundry capex funding, external customer traction, and fab build timing are clearer. A delay in Intel's process roadmap would reduce a prospective ASML order source while creating an additional downside catalyst for INTC.